Delivery Order SPE2DB20D3104-SPE2DB22FV4E4
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $7,332.15 firm fixed-price delivery order is for the supply of 10,000 units of Chorionic Gonad, a medical product. The award has an ultimate completion date of February 28, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $13,102.59 Firm Fixed Price Delivery Order is for the supply of 10,000 units of Chorionic Gonad, a pharmaceutical product. The contract has an ultimate completion date of May 3, 2024. Amerisourcebergen is a major pharmaceutical distributor that serves as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare...
- This federal contract award, with ID SPE2DB22D3004|SPE2DB24FPD12, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,095.62 firm fixed-price delivery order is for the supply of 10,000 units of Chorionic Gonad, a pharmaceutical product. The contract has an ultimate completion date of January 31, 2024 and was awarded on January 30, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 10,000 units of chorionic gonad, a pharmaceutical product, to the Defense Logistics Agency (DLA). The firm-fixed-price delivery order contract is valued at $3,783.72 and runs through July 2024. Amerisourcebergen is a major supplier of pharmaceutical and medical products to the U.S. federal government, with a focus on serving the Department of Defense (DoD) and Department of Veterans...
- Amerisourcebergen Drug Corp, through its Corporate Office division, was awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide 10,000 units of Chorionic Gonad with a potential value of $8,113.20. The contract has a completion date of February 20, 2024 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc. and is the prime contractor on this delivery order, which is issued under a larger indefinite...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999.00 through December 2025. The contract provides for the delivery of 4,556,181,518 units of Chorionic Gonad 10,000 Unit Vials, a pharmaceutical product, at a ceiling value of $6,306.20. This award has a completion date of February 8, 2022 and was...
- The federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, from the Defense Logistics Agency (DLA). The $1,199.06 firm fixed-price delivery order (SPE2DB22D1106|SPE2DB25FEGU5) is for the procurement of 10,000 units of CHORIONIC GONAD, with a completion date of April 9, 2025. This award is not associated with a set-aside designation. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
- This federal contract award, valued at $2,726.23, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support...
- This federal contract award, SPE2DB20D3104|SPE2DB22FV7H2, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $2,962.51, is for the delivery of 4,557,462,420 units of Chorionic Gonad 10,000 unit vials. The contract is a Firm Fixed Price Delivery Order with a completion date of June 8, 2022. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a critical supplier to various government...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,980.53 to AmerisourceBergen Drug Corp for the supply of 10,000 units of chorionic gonad on January 15, 2026. This firm fixed-price delivery order, with a completion date of January 16, 2026, carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger...
- SPE2DB20D3104Indefinite Delivery Contract
- SPE2DB20D3104-SPE2DB22FV4E4Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 10,000 units of Chorionic Gonad, a medical product. The fixed-price delivery order, valued at $3,281.46, has a completion date of January 4, 2022. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a for-profit organization that serves as a critical supplier of pharmaceutical products and medical supplies to various government agencies, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA). The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which runs through December 2025. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical and medical commodities to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating it was made through full and open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 1/3/22 |